ILGA, 30.10.10 Community involvement in prevention trials Gus Cairns Policy Working Group, European AIDS Treatment Group: www.eatg.org Editor, HIV Treatment.

Slides:



Advertisements
Similar presentations
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
Advertisements

The Tenofovir Trial in Cambodia In 2004 a randomized trial by investigators from the United States and Australia was planned to assess the safety and efficacy.
Learning and Empowerment: “Key Issues in Strategies for HIV/AIDS Prevention” March 1-5, 2004, Chiang Mai Presented by Dr. Pum Sophiny, Program Officer.
Ecological Model for HIV Risk in MSM Stage of Epidemic Individual Community Public Policy Network Level of Risks Source: Baral and Beyrer, 2006.
The dissemination strategy Workshop 1 Brussels, 11 October 2007 Lidia Greco & Emma Corigliano.
Daniel Driffin, MPH | Venton C. Jones Jr., MS | Christopher Chauncey Watson, MPH 2013 Creating Change January 26, 2013.
Role of the community/volunteers in the delivery of the TB/HIV package: David Coetzee February 2005 UNIVERSITY OF CAPE TOWN School of Public Health and.
51/52 IJAIYE ROAD, BESIDE UBA BANK, OGBA, IKEJA LAGOS NIGERIA. WEBSITE: PHONE NUMBER:
Community engagement in biomedical research, new perspectives of collaboration with HIV prevention research Jean-Marie Le Gall AIDES & Coalition Plus IAS.
Political commitment towards migrants Gisela Lange German Ministry of Health.
Men’s underrepresentation in HIV services: bad for men, women and health systems Dean Peacock, Sonke Gender Justice Network, July 2012.
Dr Nicholas Thomson Nossal Institute for Global Health 6th HAARP Consultation and Coordination Forum, Siem Reap, April 2012.
Our host country: Female Condoms and Microbicides in India Paramita Kundu Global Campaign for Microbicides.
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
1 Commissioned by PAMSA and German Technical Co-Operation National Certificate in Paper & Pulp Manufacturing NQF Level 2 Understand and deal with HIV/AIDS.
A South Asia multi-country Global Fund Project Round 9 Title : Reducing the impact of HIV on men who have sex with men and transgender populations in South.
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
Preparing for and Disseminating Study Results. Overview This session will cover how to: Develop and implement a dissemination plan Correctly time the.
Community Issues And Needs Associated With Microbicides Clinical Trials Presenter: John M. Mutsambi, Community Liaison Officer with University of Zimbabwe.
Making the Ethical Feasible: Assuring future access to care to those who sero-convert in microbicide trials Anna Forbes, MSS XVI.
1 From Evidence to Action Replicating and Adapting Evidence-Driven Interventions at the Local Level Shannon Thomas Ryan David Lewis-Peart.
1 GROUPWORK (1) Community Group: Rotational brainstorming problem analysis Consultation on ethical-legal complexities in adolescent HIV vaccine & microbicide.
Raising Consciousness Creating Awareness Behaviour Change Communication CHETNA STRC Ahmedabad.
Alliance2015 and HIV/AIDS prevention among the Youth: a comprehensive approach? Kwasi Boahene Chair, A2015 AIDS Policy Group HIV/AIDS Programme Manager,
Work group #2 Community based services and information.
CARLOS F. CACERES, MD, PHD PROFESSOR OF PUBLIC HEALTH CAYETANO HEREDIA UNIVERSITY DIRECTOR, INSTITUTE OF HEALTH, SEXUALTY AND HUMAN DEVELOPMENT LIMA, PERU.
Benefits of building the HIVe Why build the HIVe? How to build the HIVe Results of building the HIVe.
LESOTHO CASE STUDY. GENERAL STATS Landlocked country surrounded by South Africa Population : million Life expectancy : year Second highest.
On the ground advocacy for NPTs: advocacy, education and HIV prevention activities Kadiri Audu IRMA, Nigeria.
HIV/AIDs Case Study Australia, New Zealand, Papua New Guinea.
UK Campaign for Microbicides Rectal microbicides Need, development and advocacy Kim Mulji Executive Director Naz Foundation.
Impact of an Integrated Behavior Change Communication Program on Male Clients of Female Sex Workers in Vietnam Authors: Le Quyen Duong, Khanh Vu, Yasmin.
HIV and the media. Media reporting What do we mean by the media? What types of media do you use? What are some good things about the media? Is everything.
JOSEPH O’REILLY Deputy Chief Executive REBEKAH WEBB Policy Officer IN COLLABORATION WITH THE GLOBAL CAMPAIGN FOR MICROBICIDES IS THERE AN INVISIBLE CONDOM.
European Public Health Alliance Lobbying, the role of NGOs and communication strategies Tamsin Rose Sofia, 29 October 2005.
Multiple and Concurrent Partners: New Insights, New Tools and New Challenges Allison Herling Ruark, MSPH Harvard Center for Population and Development.
Responsible and safer places where men have sex with men.… Everywhere A European Methodological Model of HIV Prevention in Men who have Sex with Men (MSM):
AN OVERVIEW OF SPECIFIC COMMUNITIES AFFECTED BY HIV/AIDS IN CANADA Canadian Global Stakeholders’ Engagement Workshop Mark Gilbert, MD, FRCPC Director,
Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.
Educational Resources & Training
How Can Civil Society Measure Value for Money and Prove Its Worth? Amanda Glassman Center for Global Development July 26, 2012.
Population and Health Infectious and Lifestyle Diseases.
Country and community preparedness: Community Involvement in Clinical Trials Global Campaign for Microbicides.
Advocating for public health at EU level Anne Hoel and Lara Garrido-Herrero European Public Health Alliance Moscow, 28th November 2006.
Transport Against HIV/AIDS in Cambodia Maria Margarita Nunez EASTE 28 November 2007.
Building organisational capacity for sustainable LGBTI organisations Dr. Jennifer Clarke, Capacity Building Programme Coordinator.
1 Lambaa.S Member of parliament of Mongolia, Minister of Health National Conference on HIV/AIDS Hotel Chingis, Dec.2-3, 2008 Government role in prevention.
December 3, 2009 Stephen Brushett Lead Transport Specialist Latin America and the Caribbean Region The World Bank.
PrEP Update: The science, new tools, and next steps Dawn K. Smith MD, MS, MPH Division of HIV/AIDS Prevention, CDC “The findings and conclusions in this.
Addressing the Needs and Rights of Key Affected Women and Girls in Asia and the Pacific E-consultation Unzip the Lips Workshop September 2012, Bangkok,
Quality in HIV Prevention: Making Participation a Reality Prof. Dr. Michael T. Wright, LICSW, MS Quality Action Closing Conference Berlin, 27 January 2016.
Social Work Competences by Kasey Ingram IDENTIFY AS A PROFESSIONAL SOCIAL WORKER Gained more knowledge about HIV/AIDS and HCV Advocated for clients.
 Working with certain communities which are vulnerable  Sex workers  MSM  Truckers  Street children  Drug Users.
Rectal microbicides advocacy Issues, work and collaboration Kim Mulji UK rectal microbicides working group.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS H HIV Prevention for Female Sexual Partners of People Who Inject Drugs: Evaluation Results Theodore.
European Public Health Alliance Advocating for Better Health in the EU Lara Garrido-Herrero (ANME General Assembly) Frankfurt, 11 November 2006.
Microbicide Acceptability: What We Know Elizabeth McGrory Population Council May 12, 2002.
3 April 2003 Treatment as prevention: why? Gus Cairns Editor, HIV Treatment Update.
HIV prevention strategies within the Australian sex worker population - an overview of successful implementation.
The tipping point: When do placebos become unethical? Bridget Haire.
 The Work of Civil Society in the Field of HIV Prevention Brussels, 23 February 2011 The Work of European AIDS Treatment Group (EATG) 1.
Building national capacity for the implementation of safer sex mass media campaigns in Eastern Europe and Central Asia Mexico, 2008.
Some questions around efficacy and effectiveness Gus Cairns NAM Publications
Gender sensitivity and gender politics in health care Lesley Doyal.
Riga city Council Welfare department HIV prevention
Behaviour Change Communication in HIV workplace interventions
DAVID KAKHABERI.
Key Affected Populations
Presentation transcript:

ILGA, Community involvement in prevention trials Gus Cairns Policy Working Group, European AIDS Treatment Group: Editor, HIV Treatment Update, Preventing HIV and

Why involve the community? Trial acceptability/design Researching your population Community networking/testing Disseminating and communicating results

Who are “the community”? Activists Service users People at risk People not at-risk but affected Academics Healthcare providers (formal and informal) Local providers Local politicians/leaders Most of these categories overlap

What may happen if you don’t... Cambodia tenofovir PrEP trial protest, Bangkok AIDS Conference, 2004 “The issues raised by activists, academics, and the research community highlight the poor communication between stakeholders and the need for mutual understanding of values.” (Mills, BMJ, ) May have delayed PrEP research for several years

What can happen if you don’t (2) “Secret lover” (Makhwapheni) campaign, Swaziland USAID-funded national campaign targeting concurrent relationships: “Secret Lovers Kill” Led to public protest by National Association of People Living with HIV who felt it stigmatised them as “makhwapheni” Tagline changed to “Hey, HIV is Everywhere” Much more ambiguous result: debate raised in national media

The community does not speak with one voice......and shouldn’t be expected to New York “It’s never just HIV” video Reactions amongst activists ranged from praise to condemnation ‘Consulting the community’ is not rubber-stamping It may involve receiving diametrically opposed opinions

Trial acceptability/design Community needs to be actively involved in prevention trial design Likely acceptability of method A way of avoiding obvious pitfalls and assumptions Ethics check May know more than researchers about e.g. behavioural prevention methods Example: current e-group and community discussion meetings concerning proposed UK PrEP study

Researching your population Social anthropology: Who needs our intervention? Who do we target? Who are our supporters? Who will spread the word for us? Example: iPrEx trial community research : “Finding the Community in ‘Community Consultation’” (Goicochea et al CROI 2006, #898) –Identified 7 groups Academics/political campaigners Activists – CAB [NB a CAB does not = ‘the community’] Fellow prevention researchers TV and TG Feminine-identifying gay men (deschavados) Masculine-identifying gay men (buses) Male sex workers Each group may have different concerns, knowledge, level of awareness and need

Community networking/testing Once you’ve written your protocol/have your funding, will need community to further spread the word/recruit/publicise Example: TRT-5 community meetings re French Ipergay PrEP RCT First round involved 12 meetings in 10 main French cities targeting HIV ‐ negative gay people + HIV and LGBT orgs. >300 attended, 50 unaffiliated to orgs Second round of meetings happening Issue: is there such a thing as “the HIV-negative community”?

Disseminating and communicating results Examples: work of Global Campaign for Microbicides in convening community meetings to explain results of microbicide trials Small- and large-media awareness: talking to gay press etc Issue: tension between advocacy/keeping interest in the issue vs. raising premature expectations

This one was commissioned by a community NGO... ‘The community’ doesn’t always get it right “AIDS is a mass murderer” campaign Commissioned by Regenbogen, German community HIV/AIDS prevention organisation Condemned as stigmatising by other NGOs Raising awareness – or stigma?